

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular potassium ion homeostasis (GO:0030007) | 5.04378640 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 4.71670469 |
| 3 | sodium ion export (GO:0071436) | 4.67587130 |
| 4 | axon ensheathment in central nervous system (GO:0032291) | 4.50795907 |
| 5 | central nervous system myelination (GO:0022010) | 4.50795907 |
| 6 | presynaptic membrane assembly (GO:0097105) | 4.43484110 |
| 7 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.33235239 |
| 8 | presynaptic membrane organization (GO:0097090) | 4.29984680 |
| 9 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.28488736 |
| 10 | positive regulation of synapse maturation (GO:0090129) | 4.20579040 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.19817434 |
| 12 | vocalization behavior (GO:0071625) | 4.18873133 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.14699473 |
| 14 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.10551319 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.10455569 |
| 16 | neuronal action potential propagation (GO:0019227) | 3.90895734 |
| 17 | synaptic vesicle maturation (GO:0016188) | 3.86055865 |
| 18 | glutamate secretion (GO:0014047) | 3.84773704 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.84144124 |
| 20 | cell communication by electrical coupling (GO:0010644) | 3.80240114 |
| 21 | protein localization to synapse (GO:0035418) | 3.78782205 |
| 22 | membrane depolarization during action potential (GO:0086010) | 3.72317806 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.66098748 |
| 24 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.65113802 |
| 25 | regulation of cell communication by electrical coupling (GO:0010649) | 3.64032224 |
| 26 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.63414005 |
| 27 | locomotory exploration behavior (GO:0035641) | 3.62594071 |
| 28 | potassium ion homeostasis (GO:0055075) | 3.59594399 |
| 29 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.59410590 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.59321504 |
| 31 | neuron recognition (GO:0008038) | 3.53111294 |
| 32 | potassium ion import (GO:0010107) | 3.44559985 |
| 33 | fatty acid elongation (GO:0030497) | 3.44109875 |
| 34 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.43501888 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.42476772 |
| 36 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.41593561 |
| 37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.40589865 |
| 38 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.40394913 |
| 39 | regulation of synapse maturation (GO:0090128) | 3.38515023 |
| 40 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.38379531 |
| 41 | transmission of nerve impulse (GO:0019226) | 3.35539648 |
| 42 | postsynaptic membrane organization (GO:0001941) | 3.33955837 |
| 43 | glutamate receptor signaling pathway (GO:0007215) | 3.33354723 |
| 44 | positive regulation of dendritic spine development (GO:0060999) | 3.33211104 |
| 45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.33070536 |
| 46 | cell communication involved in cardiac conduction (GO:0086065) | 3.32353208 |
| 47 | regulation of synaptic vesicle transport (GO:1902803) | 3.31672943 |
| 48 | neuromuscular synaptic transmission (GO:0007274) | 3.31577401 |
| 49 | dendritic spine morphogenesis (GO:0060997) | 3.28395804 |
| 50 | negative regulation of neurotransmitter transport (GO:0051589) | 3.27863955 |
| 51 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.27624917 |
| 52 | cellular sodium ion homeostasis (GO:0006883) | 3.27157546 |
| 53 | synaptic transmission, glutamatergic (GO:0035249) | 3.26648070 |
| 54 | neuron-neuron synaptic transmission (GO:0007270) | 3.26561423 |
| 55 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.25538360 |
| 56 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.20434206 |
| 57 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.19741369 |
| 58 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.19347172 |
| 59 | neuromuscular process controlling balance (GO:0050885) | 3.18882780 |
| 60 | cerebellar granule cell differentiation (GO:0021707) | 3.18306478 |
| 61 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.17240375 |
| 62 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.15583650 |
| 63 | axonal fasciculation (GO:0007413) | 3.15567326 |
| 64 | exploration behavior (GO:0035640) | 3.14440476 |
| 65 | neurotransmitter secretion (GO:0007269) | 3.13896801 |
| 66 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.10707545 |
| 67 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.07259181 |
| 68 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.03812336 |
| 69 | layer formation in cerebral cortex (GO:0021819) | 3.02692453 |
| 70 | dendrite morphogenesis (GO:0048813) | 3.02461015 |
| 71 | amino acid import (GO:0043090) | 3.02180218 |
| 72 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.01257972 |
| 73 | L-amino acid import (GO:0043092) | 3.00745492 |
| 74 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.00493184 |
| 75 | regulation of synapse structural plasticity (GO:0051823) | 2.99163122 |
| 76 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.97611683 |
| 77 | positive regulation of membrane potential (GO:0045838) | 2.96943019 |
| 78 | regulation of membrane repolarization (GO:0060306) | 2.96514635 |
| 79 | long-term synaptic potentiation (GO:0060291) | 2.94227748 |
| 80 | positive regulation of neurotransmitter transport (GO:0051590) | 2.93802316 |
| 81 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.92876054 |
| 82 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.90223535 |
| 83 | neurotransmitter uptake (GO:0001504) | 2.90014394 |
| 84 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.89114573 |
| 85 | establishment of mitochondrion localization (GO:0051654) | 2.87865137 |
| 86 | adult walking behavior (GO:0007628) | 2.86474349 |
| 87 | cell differentiation in hindbrain (GO:0021533) | 2.85886213 |
| 88 | myelination (GO:0042552) | 2.84858675 |
| 89 | regulation of postsynaptic membrane potential (GO:0060078) | 2.84045380 |
| 90 | activation of protein kinase A activity (GO:0034199) | 2.83941744 |
| 91 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.82310323 |
| 92 | axon ensheathment (GO:0008366) | 2.81636393 |
| 93 | ensheathment of neurons (GO:0007272) | 2.81636393 |
| 94 | proline transport (GO:0015824) | 2.79949969 |
| 95 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.78342223 |
| 96 | neurotransmitter transport (GO:0006836) | 2.77392347 |
| 97 | long-term memory (GO:0007616) | 2.76011002 |
| 98 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.75578901 |
| 99 | auditory behavior (GO:0031223) | 2.74832748 |
| 100 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.73651102 |
| 101 | positive regulation of synapse assembly (GO:0051965) | 2.72729382 |
| 102 | regulation of neurotransmitter secretion (GO:0046928) | 2.72688835 |
| 103 | neuronal ion channel clustering (GO:0045161) | 2.72365843 |
| 104 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.71254410 |
| 105 | synapse assembly (GO:0007416) | 2.69938819 |
| 106 | regulation of synaptic plasticity (GO:0048167) | 2.69040058 |
| 107 | startle response (GO:0001964) | 2.66215725 |
| 108 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.66072021 |
| 109 | regulation of dendritic spine development (GO:0060998) | 2.63628206 |
| 110 | membrane hyperpolarization (GO:0060081) | 2.62912498 |
| 111 | mechanosensory behavior (GO:0007638) | 2.60220708 |
| 112 | membrane assembly (GO:0071709) | 2.59655598 |
| 113 | negative regulation of axonogenesis (GO:0050771) | 2.59548216 |
| 114 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.58728648 |
| 115 | mating behavior (GO:0007617) | 2.57792793 |
| 116 | response to auditory stimulus (GO:0010996) | 2.57424014 |
| 117 | neuron remodeling (GO:0016322) | 2.57321215 |
| 118 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.55643450 |
| 119 | learning (GO:0007612) | 2.55545277 |
| 120 | cell migration in hindbrain (GO:0021535) | 2.54961637 |
| 121 | negative regulation of protein localization to cell surface (GO:2000009) | 2.54711572 |
| 122 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.54455613 |
| 123 | regulation of neurotransmitter transport (GO:0051588) | 2.54034350 |
| 124 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.53783463 |
| 125 | behavioral response to cocaine (GO:0048148) | 2.53194940 |
| 126 | membrane depolarization (GO:0051899) | 2.53017939 |
| 127 | regulation of neurotransmitter levels (GO:0001505) | 2.52913595 |
| 128 | synapse organization (GO:0050808) | 2.52438514 |
| 129 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.52170415 |
| 130 | dendrite development (GO:0016358) | 2.50817973 |
| 131 | regulation of vesicle fusion (GO:0031338) | 2.50667700 |
| 132 | negative regulation of axon extension (GO:0030517) | 2.45857527 |
| 133 | detection of calcium ion (GO:0005513) | 2.44250303 |
| 134 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.42547118 |
| 135 | synaptic vesicle endocytosis (GO:0048488) | 2.41826911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.75094248 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.74014505 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.95189679 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.89273584 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.77145821 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46807175 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46807175 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45318943 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42005825 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40366759 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38338360 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.38197146 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.34611275 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34440484 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.30970522 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21094864 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14975884 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.14820604 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14421460 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.00012787 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.99063340 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94527182 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88946909 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.85263986 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.83497797 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78326531 |
| 27 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.77696455 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77503233 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.77098581 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.72592192 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.67915566 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67372700 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66533580 |
| 34 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61843858 |
| 35 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.61164917 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57384552 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.54165627 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53866654 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.51837173 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.50148181 |
| 41 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.49125518 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46589365 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.46031006 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44751912 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42849156 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42148304 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41647065 |
| 48 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41067253 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38559589 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38137801 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37432228 |
| 52 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33003849 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.31015462 |
| 54 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.28523459 |
| 55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28508304 |
| 56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27933369 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25954610 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25560445 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25046278 |
| 60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24976261 |
| 61 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.24312752 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23440451 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22498741 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19792207 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19290079 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15934722 |
| 67 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.15824519 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15814928 |
| 69 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15809039 |
| 70 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14694022 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13818679 |
| 72 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.13364940 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13166437 |
| 74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12347317 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11157110 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11056229 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.10831485 |
| 78 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10466577 |
| 79 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10051440 |
| 80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09954150 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09471458 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08409612 |
| 83 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08225665 |
| 84 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04204020 |
| 85 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03910965 |
| 86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03770926 |
| 87 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01436503 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01046458 |
| 89 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.99648262 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99319856 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99305353 |
| 92 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99293225 |
| 93 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99275544 |
| 94 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98907522 |
| 95 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98878993 |
| 96 | AR_19668381_ChIP-Seq_PC3_Human | 0.96404253 |
| 97 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96098515 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94566216 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94566216 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94132302 |
| 101 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93823608 |
| 102 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91589422 |
| 103 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91191712 |
| 104 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91053950 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90848217 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89625258 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89625258 |
| 108 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.89495286 |
| 109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88294763 |
| 110 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87135586 |
| 111 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86750328 |
| 112 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86702291 |
| 113 | JUN_21703547_ChIP-Seq_K562_Human | 0.86379300 |
| 114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85680469 |
| 115 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85335597 |
| 116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85130102 |
| 117 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84236699 |
| 118 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.84231701 |
| 119 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83743061 |
| 120 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82785218 |
| 121 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.82602208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.84190129 |
| 2 | MP0003880_abnormal_central_pattern | 4.74970492 |
| 3 | MP0004270_analgesia | 3.57222206 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.48224586 |
| 5 | MP0009745_abnormal_behavioral_response | 3.03104422 |
| 6 | MP0002064_seizures | 3.01402283 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.85886497 |
| 8 | MP0009046_muscle_twitch | 2.83442168 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.67346561 |
| 10 | MP0002272_abnormal_nervous_system | 2.63136700 |
| 11 | MP0001486_abnormal_startle_reflex | 2.61647555 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.60790178 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.55451614 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.52705694 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.38205204 |
| 16 | MP0003329_amyloid_beta_deposits | 2.32558375 |
| 17 | MP0000920_abnormal_myelination | 2.28948840 |
| 18 | MP0000778_abnormal_nervous_system | 2.23668156 |
| 19 | MP0002736_abnormal_nociception_after | 2.19601372 |
| 20 | MP0002822_catalepsy | 2.11101865 |
| 21 | MP0001529_abnormal_vocalization | 2.00730618 |
| 22 | MP0001440_abnormal_grooming_behavior | 1.97277174 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.95708139 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.94872950 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.89123120 |
| 26 | MP0001970_abnormal_pain_threshold | 1.88982174 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.87584165 |
| 28 | MP0001905_abnormal_dopamine_level | 1.86225403 |
| 29 | MP0004885_abnormal_endolymph | 1.79328678 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.78862117 |
| 31 | MP0008569_lethality_at_weaning | 1.72591985 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.72393492 |
| 33 | MP0004924_abnormal_behavior | 1.72393492 |
| 34 | MP0000749_muscle_degeneration | 1.70574468 |
| 35 | MP0003690_abnormal_glial_cell | 1.70414248 |
| 36 | MP0002184_abnormal_innervation | 1.68188935 |
| 37 | MP0001984_abnormal_olfaction | 1.62788444 |
| 38 | MP0004142_abnormal_muscle_tone | 1.60667133 |
| 39 | MP0004742_abnormal_vestibular_system | 1.56741467 |
| 40 | MP0000955_abnormal_spinal_cord | 1.55889706 |
| 41 | MP0002557_abnormal_social/conspecific_i | 1.55082876 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.46871189 |
| 43 | MP0003634_abnormal_glial_cell | 1.46607440 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.44682434 |
| 45 | MP0002066_abnormal_motor_capabilities/c | 1.44380874 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.41940458 |
| 47 | MP0002229_neurodegeneration | 1.36265272 |
| 48 | MP0003633_abnormal_nervous_system | 1.33682254 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.31179385 |
| 50 | MP0002638_abnormal_pupillary_reflex | 1.30983259 |
| 51 | MP0003631_nervous_system_phenotype | 1.25885568 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.23751368 |
| 53 | MP0003123_paternal_imprinting | 1.23566965 |
| 54 | MP0000604_amyloidosis | 1.22322342 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.21431665 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.20133383 |
| 57 | MP0003632_abnormal_nervous_system | 1.17506648 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.17195863 |
| 59 | MP0003646_muscle_fatigue | 1.16378576 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 1.15904554 |
| 61 | MP0004858_abnormal_nervous_system | 1.10787786 |
| 62 | MP0005171_absent_coat_pigmentation | 1.09279768 |
| 63 | MP0004043_abnormal_pH_regulation | 1.07053057 |
| 64 | MP0000751_myopathy | 1.06564566 |
| 65 | MP0001963_abnormal_hearing_physiology | 1.06156378 |
| 66 | MP0002106_abnormal_muscle_physiology | 1.04192506 |
| 67 | MP0003879_abnormal_hair_cell | 1.01918048 |
| 68 | MP0005620_abnormal_muscle_contractility | 1.01396338 |
| 69 | MP0001188_hyperpigmentation | 1.00463043 |
| 70 | MP0004084_abnormal_cardiac_muscle | 0.99406215 |
| 71 | MP0004510_myositis | 0.99130873 |
| 72 | MP0002152_abnormal_brain_morphology | 0.98824670 |
| 73 | MP0002090_abnormal_vision | 0.98745159 |
| 74 | MP0000013_abnormal_adipose_tissue | 0.97317330 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 0.95257043 |
| 76 | MP0004087_abnormal_muscle_fiber | 0.95192004 |
| 77 | MP0005409_darkened_coat_color | 0.94694835 |
| 78 | MP0002752_abnormal_somatic_nervous | 0.94405051 |
| 79 | MP0001485_abnormal_pinna_reflex | 0.92295621 |
| 80 | MP0002332_abnormal_exercise_endurance | 0.91779990 |
| 81 | MP0001177_atelectasis | 0.90673825 |
| 82 | MP0000759_abnormal_skeletal_muscle | 0.90416070 |
| 83 | MP0002069_abnormal_eating/drinking_beha | 0.87223896 |
| 84 | MP0002876_abnormal_thyroid_physiology | 0.86035594 |
| 85 | MP0005369_muscle_phenotype | 0.85175326 |
| 86 | MP0004085_abnormal_heartbeat | 0.80918970 |
| 87 | MP0003787_abnormal_imprinting | 0.80001032 |
| 88 | MP0005535_abnormal_body_temperature | 0.78883790 |
| 89 | MP0001299_abnormal_eye_distance/ | 0.75433376 |
| 90 | MP0001664_abnormal_digestion | 0.73856460 |
| 91 | MP0002972_abnormal_cardiac_muscle | 0.73479656 |
| 92 | MP0003121_genomic_imprinting | 0.73268755 |
| 93 | MP0000631_abnormal_neuroendocrine_gland | 0.72716510 |
| 94 | MP0008874_decreased_physiological_sensi | 0.72069996 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.71198266 |
| 96 | MP0002269_muscular_atrophy | 0.71167050 |
| 97 | MP0003195_calcinosis | 0.70077291 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.69354148 |
| 99 | MP0000026_abnormal_inner_ear | 0.68945520 |
| 100 | MP0005623_abnormal_meninges_morphology | 0.67014158 |
| 101 | MP0003137_abnormal_impulse_conducting | 0.66425399 |
| 102 | MP0008877_abnormal_DNA_methylation | 0.66303151 |
| 103 | MP0003122_maternal_imprinting | 0.66201859 |
| 104 | MP0004036_abnormal_muscle_relaxation | 0.65806309 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 0.64115157 |
| 106 | MP0000750_abnormal_muscle_regeneration | 0.63642218 |
| 107 | MP0004134_abnormal_chest_morphology | 0.62453935 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.60215690 |
| 109 | MP0005253_abnormal_eye_physiology | 0.59307187 |
| 110 | MP0005195_abnormal_posterior_eye | 0.59070068 |
| 111 | MP0004130_abnormal_muscle_cell | 0.57723431 |
| 112 | MP0001346_abnormal_lacrimal_gland | 0.57050104 |
| 113 | MP0001943_abnormal_respiration | 0.56529015 |
| 114 | MP0000747_muscle_weakness | 0.55664796 |
| 115 | MP0004484_altered_response_of | 0.55138048 |
| 116 | MP0003075_altered_response_to | 0.54878429 |
| 117 | MP0008872_abnormal_physiological_respon | 0.54500625 |
| 118 | MP0004215_abnormal_myocardial_fiber | 0.50337996 |
| 119 | MP0005410_abnormal_fertilization | 0.49069006 |
| 120 | MP0004147_increased_porphyrin_level | 0.47459878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.80792310 |
| 2 | Myokymia (HP:0002411) | 4.95942434 |
| 3 | Neurofibrillary tangles (HP:0002185) | 4.68468655 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.28592490 |
| 5 | Focal seizures (HP:0007359) | 4.13945676 |
| 6 | Muscle fiber inclusion bodies (HP:0100299) | 4.12677740 |
| 7 | Atonic seizures (HP:0010819) | 4.07766200 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 4.04695906 |
| 9 | Nemaline bodies (HP:0003798) | 4.02417422 |
| 10 | Hyperventilation (HP:0002883) | 3.99866031 |
| 11 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.96550967 |
| 12 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.95657632 |
| 13 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.95657632 |
| 14 | Abnormality of the corticospinal tract (HP:0002492) | 3.90809620 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.84109334 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 3.61536369 |
| 17 | Visual hallucinations (HP:0002367) | 3.54403454 |
| 18 | Exercise-induced myalgia (HP:0003738) | 3.37048643 |
| 19 | Insidious onset (HP:0003587) | 3.25421885 |
| 20 | Termporal pattern (HP:0011008) | 3.25421885 |
| 21 | Febrile seizures (HP:0002373) | 3.23001160 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 3.20999189 |
| 23 | Bundle branch block (HP:0011710) | 3.19036162 |
| 24 | Broad-based gait (HP:0002136) | 3.17379955 |
| 25 | Ankle clonus (HP:0011448) | 3.12323962 |
| 26 | Absence seizures (HP:0002121) | 3.11334803 |
| 27 | Spastic gait (HP:0002064) | 3.11111588 |
| 28 | Pheochromocytoma (HP:0002666) | 3.09412206 |
| 29 | Action tremor (HP:0002345) | 3.07331298 |
| 30 | Progressive inability to walk (HP:0002505) | 3.00752413 |
| 31 | Dysmetria (HP:0001310) | 2.99614073 |
| 32 | Dialeptic seizures (HP:0011146) | 2.98286176 |
| 33 | Intention tremor (HP:0002080) | 2.90766285 |
| 34 | Akinesia (HP:0002304) | 2.90183186 |
| 35 | Generalized tonic-clonic seizures (HP:0002069) | 2.90101874 |
| 36 | Difficulty running (HP:0009046) | 2.89057395 |
| 37 | Scanning speech (HP:0002168) | 2.86692138 |
| 38 | Sudden death (HP:0001699) | 2.85726976 |
| 39 | Type 1 muscle fiber predominance (HP:0003803) | 2.82821512 |
| 40 | Limb dystonia (HP:0002451) | 2.81702213 |
| 41 | Hyporeflexia of lower limbs (HP:0002600) | 2.78457519 |
| 42 | Neuroendocrine neoplasm (HP:0100634) | 2.76070673 |
| 43 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.70697776 |
| 44 | Abnormal eating behavior (HP:0100738) | 2.69842148 |
| 45 | EMG: myopathic abnormalities (HP:0003458) | 2.67915933 |
| 46 | Anxiety (HP:0000739) | 2.63545395 |
| 47 | Muscle fiber splitting (HP:0003555) | 2.61446133 |
| 48 | Sensory axonal neuropathy (HP:0003390) | 2.58148630 |
| 49 | Calf muscle hypertrophy (HP:0008981) | 2.56622147 |
| 50 | Mutism (HP:0002300) | 2.55618214 |
| 51 | Excessive salivation (HP:0003781) | 2.54665669 |
| 52 | Drooling (HP:0002307) | 2.54665669 |
| 53 | Truncal ataxia (HP:0002078) | 2.53770628 |
| 54 | Frequent falls (HP:0002359) | 2.52448997 |
| 55 | Peripheral hypomyelination (HP:0007182) | 2.47427084 |
| 56 | Status epilepticus (HP:0002133) | 2.47148716 |
| 57 | Polyphagia (HP:0002591) | 2.44716164 |
| 58 | Cerebral hypomyelination (HP:0006808) | 2.44376146 |
| 59 | Hemiplegia (HP:0002301) | 2.43747138 |
| 60 | Myotonia (HP:0002486) | 2.43185166 |
| 61 | Ventricular fibrillation (HP:0001663) | 2.42709105 |
| 62 | Retinal dysplasia (HP:0007973) | 2.42366511 |
| 63 | Dysdiadochokinesis (HP:0002075) | 2.42053932 |
| 64 | Lower limb amyotrophy (HP:0007210) | 2.39432623 |
| 65 | Thickened helices (HP:0000391) | 2.39296854 |
| 66 | Gaze-evoked nystagmus (HP:0000640) | 2.37375291 |
| 67 | Tetraplegia (HP:0002445) | 2.37246871 |
| 68 | Megalencephaly (HP:0001355) | 2.36744215 |
| 69 | Poor eye contact (HP:0000817) | 2.36555777 |
| 70 | Amblyopia (HP:0000646) | 2.36229420 |
| 71 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.34910613 |
| 72 | EMG: neuropathic changes (HP:0003445) | 2.34762548 |
| 73 | Blue irides (HP:0000635) | 2.34224354 |
| 74 | Depression (HP:0000716) | 2.34132818 |
| 75 | Urinary urgency (HP:0000012) | 2.33080263 |
| 76 | Heart block (HP:0012722) | 2.29564730 |
| 77 | Papilledema (HP:0001085) | 2.29514123 |
| 78 | Lower limb muscle weakness (HP:0007340) | 2.29422403 |
| 79 | Distal arthrogryposis (HP:0005684) | 2.27981950 |
| 80 | Inability to walk (HP:0002540) | 2.27541749 |
| 81 | Generalized myoclonic seizures (HP:0002123) | 2.26302701 |
| 82 | Epileptiform EEG discharges (HP:0011182) | 2.25773508 |
| 83 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.25066537 |
| 84 | Obstructive sleep apnea (HP:0002870) | 2.23949796 |
| 85 | Torticollis (HP:0000473) | 2.23765603 |
| 86 | Abnormality of the calf musculature (HP:0001430) | 2.23685698 |
| 87 | Dysmetric saccades (HP:0000641) | 2.22692994 |
| 88 | Increased circulating renin level (HP:0000848) | 2.22079737 |
| 89 | Abnormality of the lower motor neuron (HP:0002366) | 2.21904990 |
| 90 | Abnormality of binocular vision (HP:0011514) | 2.21028975 |
| 91 | Diplopia (HP:0000651) | 2.21028975 |
| 92 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17330115 |
| 93 | Abnormal social behavior (HP:0012433) | 2.14478667 |
| 94 | Impaired social interactions (HP:0000735) | 2.14478667 |
| 95 | Rimmed vacuoles (HP:0003805) | 2.14336637 |
| 96 | Onion bulb formation (HP:0003383) | 2.14240004 |
| 97 | Bradykinesia (HP:0002067) | 2.12821228 |
| 98 | Hemiparesis (HP:0001269) | 2.12674919 |
| 99 | Neuronal loss in central nervous system (HP:0002529) | 2.10841756 |
| 100 | Clonus (HP:0002169) | 2.09728411 |
| 101 | Impaired vibratory sensation (HP:0002495) | 2.09399321 |
| 102 | Abnormality of the foot musculature (HP:0001436) | 2.08434699 |
| 103 | Absent speech (HP:0001344) | 2.08359227 |
| 104 | Foot dorsiflexor weakness (HP:0009027) | 2.08317148 |
| 105 | Hypsarrhythmia (HP:0002521) | 2.08182428 |
| 106 | Syncope (HP:0001279) | 2.07491805 |
| 107 | Prolonged QT interval (HP:0001657) | 2.07314251 |
| 108 | Focal dystonia (HP:0004373) | 2.07058353 |
| 109 | Rapidly progressive (HP:0003678) | 2.06949462 |
| 110 | Abnormal atrioventricular conduction (HP:0005150) | 2.06400289 |
| 111 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.05307758 |
| 112 | Acute necrotizing encephalopathy (HP:0006965) | 2.04844974 |
| 113 | Myopathic facies (HP:0002058) | 2.03073625 |
| 114 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01656883 |
| 115 | Fetal akinesia sequence (HP:0001989) | 2.00461243 |
| 116 | Incomplete penetrance (HP:0003829) | 1.98216382 |
| 117 | Aplasia involving bones of the extremities (HP:0009825) | 1.96986024 |
| 118 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.96986024 |
| 119 | Aplasia of the phalanges of the hand (HP:0009802) | 1.96986024 |
| 120 | Sleep apnea (HP:0010535) | 1.96947598 |
| 121 | Rigidity (HP:0002063) | 1.95837892 |
| 122 | Craniofacial dystonia (HP:0012179) | 1.95114479 |
| 123 | Gait imbalance (HP:0002141) | 1.94790007 |
| 124 | Leukodystrophy (HP:0002415) | 1.94379218 |
| 125 | Parakeratosis (HP:0001036) | 1.93985977 |
| 126 | Hypoplasia of the brainstem (HP:0002365) | 1.92568952 |
| 127 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.92568952 |
| 128 | Type II lissencephaly (HP:0007260) | 1.91978252 |
| 129 | Progressive macrocephaly (HP:0004481) | 1.91692615 |
| 130 | Cerebral hemorrhage (HP:0001342) | 1.91435592 |
| 131 | Postural instability (HP:0002172) | 1.90479582 |
| 132 | Psychosis (HP:0000709) | 1.89498128 |
| 133 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.89036216 |
| 134 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.87222714 |
| 135 | Agitation (HP:0000713) | 1.81776369 |
| 136 | Increased serum pyruvate (HP:0003542) | 1.80722232 |
| 137 | Abnormality of glycolysis (HP:0004366) | 1.80722232 |
| 138 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.80687987 |
| 139 | Abnormality of salivation (HP:0100755) | 1.78534827 |
| 140 | Stereotypic behavior (HP:0000733) | 1.76170032 |
| 141 | Clumsiness (HP:0002312) | 1.76164565 |
| 142 | Esotropia (HP:0000565) | 1.75638462 |
| 143 | Specific learning disability (HP:0001328) | 1.75479522 |
| 144 | Acute encephalopathy (HP:0006846) | 1.74581232 |
| 145 | Gait ataxia (HP:0002066) | 1.74054743 |
| 146 | Slow saccadic eye movements (HP:0000514) | 1.72774604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 3.58568232 |
| 2 | CASK | 3.20831373 |
| 3 | OBSCN | 3.19370898 |
| 4 | EPHA4 | 3.14077663 |
| 5 | STK39 | 2.86029493 |
| 6 | OXSR1 | 2.73924705 |
| 7 | NTRK3 | 2.73079215 |
| 8 | MAP3K4 | 2.43003406 |
| 9 | MAP2K7 | 2.42996209 |
| 10 | TNIK | 2.28008389 |
| 11 | MAP3K9 | 2.22804630 |
| 12 | CDK19 | 2.07382224 |
| 13 | MINK1 | 1.96253842 |
| 14 | NTRK2 | 1.89018546 |
| 15 | DAPK2 | 1.82222526 |
| 16 | PAK6 | 1.68869080 |
| 17 | NTRK1 | 1.68630718 |
| 18 | PRPF4B | 1.59683373 |
| 19 | PNCK | 1.55417597 |
| 20 | MAP2K4 | 1.53601212 |
| 21 | MAPK13 | 1.50149857 |
| 22 | LATS2 | 1.46450633 |
| 23 | SGK494 | 1.43678675 |
| 24 | SGK223 | 1.43678675 |
| 25 | PKN1 | 1.43417200 |
| 26 | CDK5 | 1.42625871 |
| 27 | WNK4 | 1.40523496 |
| 28 | BCR | 1.36886646 |
| 29 | UHMK1 | 1.36725340 |
| 30 | PHKG2 | 1.35469610 |
| 31 | PHKG1 | 1.35469610 |
| 32 | PLK2 | 1.30330999 |
| 33 | CAMK2B | 1.27871941 |
| 34 | MAP3K12 | 1.26354578 |
| 35 | FGFR2 | 1.15923130 |
| 36 | CSNK1G2 | 1.14510463 |
| 37 | KSR2 | 1.12462856 |
| 38 | RIPK4 | 1.12174227 |
| 39 | CAMK2A | 1.10602652 |
| 40 | FES | 1.07360688 |
| 41 | RIPK1 | 1.07188665 |
| 42 | GRK5 | 1.06257575 |
| 43 | EPHB1 | 1.03197128 |
| 44 | PAK3 | 1.02453452 |
| 45 | ARAF | 1.00511350 |
| 46 | KSR1 | 0.99593262 |
| 47 | MAPKAPK5 | 0.98048204 |
| 48 | TTN | 0.97269800 |
| 49 | SGK3 | 0.93916381 |
| 50 | CSNK1G3 | 0.93797732 |
| 51 | CAMK2D | 0.92695248 |
| 52 | DYRK2 | 0.91678736 |
| 53 | PRKCE | 0.90532337 |
| 54 | PRKCG | 0.90529442 |
| 55 | WNK1 | 0.90359771 |
| 56 | FGR | 0.87134655 |
| 57 | CDK14 | 0.85848150 |
| 58 | CAMKK2 | 0.85536958 |
| 59 | CDK18 | 0.85135508 |
| 60 | MUSK | 0.83250982 |
| 61 | CDK15 | 0.82905327 |
| 62 | DYRK1A | 0.82607600 |
| 63 | MARK2 | 0.81119698 |
| 64 | NEK6 | 0.79260431 |
| 65 | TYRO3 | 0.79129431 |
| 66 | LIMK1 | 0.78072922 |
| 67 | PRKCH | 0.77424000 |
| 68 | SIK2 | 0.76571630 |
| 69 | CSNK1A1L | 0.75516910 |
| 70 | ROCK2 | 0.75018584 |
| 71 | BMPR1B | 0.74101042 |
| 72 | MAP3K13 | 0.73821833 |
| 73 | CAMK2G | 0.72665026 |
| 74 | MAP3K2 | 0.72531710 |
| 75 | CAMKK1 | 0.72310775 |
| 76 | CDK11A | 0.71405318 |
| 77 | MAPK10 | 0.70900521 |
| 78 | STK38 | 0.68954643 |
| 79 | PRKD3 | 0.68810289 |
| 80 | CAMK4 | 0.68729571 |
| 81 | SGK2 | 0.68159871 |
| 82 | CCNB1 | 0.66613852 |
| 83 | BMPR2 | 0.66053420 |
| 84 | DAPK1 | 0.65444150 |
| 85 | ALK | 0.63387097 |
| 86 | WNK3 | 0.62439000 |
| 87 | RPS6KA3 | 0.61845557 |
| 88 | FYN | 0.61077291 |
| 89 | CSNK1G1 | 0.60805787 |
| 90 | PTK2B | 0.60795352 |
| 91 | MAPK12 | 0.60332685 |
| 92 | CAMK1G | 0.57538957 |
| 93 | STK11 | 0.57406459 |
| 94 | MAPK15 | 0.56713286 |
| 95 | RET | 0.55702102 |
| 96 | PDPK1 | 0.55636331 |
| 97 | PINK1 | 0.54642787 |
| 98 | SGK1 | 0.54421442 |
| 99 | DMPK | 0.53130910 |
| 100 | PRKCQ | 0.52568275 |
| 101 | CAMK1 | 0.50027024 |
| 102 | ERBB3 | 0.49148393 |
| 103 | GRK7 | 0.47717201 |
| 104 | PRKCZ | 0.45750362 |
| 105 | PRKAA1 | 0.44756513 |
| 106 | NME1 | 0.44590346 |
| 107 | INSRR | 0.44485243 |
| 108 | MAPK7 | 0.44133101 |
| 109 | MAP3K7 | 0.44046842 |
| 110 | ROCK1 | 0.43721384 |
| 111 | PIK3CA | 0.43590617 |
| 112 | PRKG1 | 0.43223983 |
| 113 | PRKACA | 0.43077817 |
| 114 | PDK1 | 0.42297871 |
| 115 | TRIM28 | 0.41356377 |
| 116 | LMTK2 | 0.40679309 |
| 117 | BRAF | 0.38746046 |
| 118 | RAF1 | 0.37625548 |
| 119 | CSNK1D | 0.36638500 |
| 120 | RPS6KB1 | 0.33467858 |
| 121 | MOS | 0.33035803 |
| 122 | PRKCA | 0.32191049 |
| 123 | MAP2K1 | 0.32160323 |
| 124 | MAPK4 | 0.30349472 |
| 125 | DAPK3 | 0.29358077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.04510291 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.85857832 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.45483592 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.41627758 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.41551228 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.19278699 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.17618657 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.17171318 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.14772181 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.06793679 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.04461859 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.87681319 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.77811515 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.77726581 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 1.74169208 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.71706798 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.61217213 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.59296482 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.55416423 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.54741315 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.53049335 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.50682074 |
| 23 | Axon guidance_Homo sapiens_hsa04360 | 1.48338223 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.45992841 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.45382578 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44816981 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40457505 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.39788259 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39239193 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.38083345 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34771605 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.34410409 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.34199625 |
| 34 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.28672088 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.22767049 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21340512 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.19133580 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.16355794 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15240444 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13842361 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13356586 |
| 42 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.12931108 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 1.09974209 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08780060 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.05885711 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04513996 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03322284 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01044444 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 0.98267284 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97567974 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 0.96680301 |
| 52 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.94260082 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92134786 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.91051028 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90942455 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84888542 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84757940 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83917795 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83734019 |
| 60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.81183213 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80065610 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77871865 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75789916 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75598864 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74730805 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72567188 |
| 67 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.71188049 |
| 68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70482162 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69151317 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69125214 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68939919 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67767673 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67113475 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66879352 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63840302 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63311844 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61835096 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61625987 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.61323558 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.60302946 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59907495 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59762297 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59412690 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59226908 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57549898 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56104288 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55255362 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.54811401 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53911432 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52707417 |
| 91 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50165776 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49291983 |
| 93 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49184279 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.48418663 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46556903 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46328072 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46156756 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.45811408 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44748946 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43548421 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.43217810 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42950592 |
| 103 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42477099 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42127202 |
| 105 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41769454 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41275365 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40678955 |
| 108 | Alcoholism_Homo sapiens_hsa05034 | 0.39953828 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39755532 |
| 110 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39379550 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38083849 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37424311 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36274591 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36249258 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35376706 |
| 116 | Bile secretion_Homo sapiens_hsa04976 | 0.35259431 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32582435 |
| 118 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32180437 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31707611 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31150686 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30859308 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30486012 |
| 123 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28909370 |
| 124 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28797207 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28412819 |
| 126 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.28187807 |
| 127 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.26857575 |

